| |
 |
|
|
|
|
| Seikagaku's US Subsidiary Receives FDA Approval for New LAL Reagent Plant |
|
|
|
Tokyo, Mar 10, 2004 (JCN) - Seikagaku announced on March 8 that its US consolidated subsidiary Associates of Cape Cod has had its new plant approved by the US Food and Drug Administration.
Upon this approval, the new plant will launch commercial operations and manufacture "Pyrotell-Multitest" and "Pyrotell-T," LAL (limulus amebocyte lysate) reagents that are used to detect endotoxins.
Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
Seikagaku Obtains Sales Distribution Approval for MukoUp
(Oct 20, 2006)
|
|
|
Seikagaku to Begin Clinical Trials of Injectable Hyaluronic Acid Gel for Knee Osteoarthritis Treatment in US
(July 20, 2006)
|
|
|
AnGes MG, Seikagaku to Dissolve Joint Development Agreement for NFkB Decoy-Oligo-based Intraarticular Injection
(Feb 6, 2006)
|
|
|
Seikagaku to Boost ARTZ Dispo Production Capacity
(Nov 14, 2005)
|
|
|
Seikagaku, Discovery Partners International Identify Drug Compound Candidates That Target Sugar Chain Enzymes
(Nov 11, 2005)
|
|
|
Seikagaku Introduces New Reagent Kit for Basic Sodium Hyaluronate Research
(July 21, 2004)
|
|
|
Seikagaku Halts Development of New Interstitial Cystitis Drug
(Mar 10, 2004)
|
|
|
Seikagaku's US Subsidiary Receives FDA Approval for New LAL Reagent Plant
(Mar 10, 2004)
|
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
Otsuka Launches First Skin Patch Treatment for Parkinson's Disease and Restless Legs Syndrome (Feb 22, 2013)
|
|
|
Teijin Launches Polyester Curtain Fabric with Enhanced Pollen-trapping (Feb 21, 2013)
|
|
|
Toyota Tsusho Opens Medical Clinic in Thai Plant (Feb 18, 2013)
|
|
|
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy (Feb 15, 2013)
|
|
|
Dainippon Sumitomo Pharma Opens Subsidiary in Singapore (Jan 22, 2013)
|
|
|
Teijin and InCube Labs Enter Strategic Partnership in Healthcare Business (Jan 22, 2013)
|
|
|
Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent (Jan 9, 2013)
|
|
|
Takara Bio Initiates Phase 1 HIV Gene Therapy Clinical Trial (Jan 7, 2013)
|
|
|
Kobe University, KNC Labs and Dainippon Sumitomo to Research Anti-cancer Agent (Dec 28, 2012)
|
|
|
Daiichi Sankyo Introduces Alzheimer's Disease Awareness Campaign (Dec 20, 2012)
|
More Drugs & OTC news...
|
|
|
|
|
|
|
|
|
|
